Harry Sloan, Director at Ginkgo Bioworks Holdings, Inc. (DNA), bought 595,238 shares at $0.91 ($542K) on 2024-05-14, disclosed to the SEC on 2024-05-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.91 | 297,619 | $271K | 50.0% |
| 2 | $0.91 | 297,619 | $271K | 50.0% |
| Total | $0.91 avg | 595,238 | $542K | 100% |
| Filing → |
| STRZ | BUY | 2025-08-21 | $285K | — | Filing → |
| DKNG | SELL | 2024-06-14 | $9.5M | — | Filing → |
| DNA | BUY | 2023-05-22 | $448K | — | Filing → |